Recurrent Thyroid Gland Carcinoma

specific

The reemergence of thyroid gland carcinoma after a period of remission.

Centers

128

Active Trials

—

Cancer Funding

Top Centers for Recurrent Thyroid Gland Carcinoma(79)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center	High-Volume Research Center	3	—	72.8
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
3	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
4	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
5	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
6	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
7	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
8	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
9	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
10	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
11	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
12	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
13	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
14	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
15	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
16	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
17	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
18	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
19	UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program	Active Research Program	2	—	59.2
20	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
21	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
22	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	2	—	59.2
23	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
24	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	2	—	59.2
25	Cedars-Sinai CancerLos Angeles, CA Active Research Program	Active Research Program	2	—	59.2
26	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
27	UMass Memorial Health Cancer CenterWorcester, MA Active Research Program	Active Research Program	2	—	59.2
28	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	2	—	59.2
29	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	2	—	59.2
30	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
31	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
32	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
33	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	59.2
34	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program	Active Research Program	2	—	59.2
35	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	2	—	59.2
36	Boston University Cancer CenterBoston, MA Active Research Program	Active Research Program	2	—	59.2
37	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program	Active Research Program	2	—	59.2
38	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	2	—	59.2
39	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	2	—	59.2
40	Stony Brook Cancer CenterStony Brook, NY Active Research Program	Active Research Program	2	—	59.2
41	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	2	—	59.2
42	Livestrong Cancer InstitutesAustin, TX Active Research Program	Active Research Program	2	—	59.2
43	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	2	—	59.2
44	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR Active Research Program	Active Research Program	2	—	59.2
45	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	2	—	59.2
46	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	2	—	59.2
47	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	2	—	59.2
48	Tampa General Hospital Cancer InstituteTampa, FL Active Research Program	Active Research Program	2	—	59.2
49	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
50	University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
51	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
52	UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
53	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
54	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
55	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
56	Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
57	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
58	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
59	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
60	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
61	Montefiore Einstein Comprehensive Cancer CenterBronx, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
62	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
63	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
64	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
65	Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
66	Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
67	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
68	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
69	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	1	—	37.0
70	Penn State Cancer InstituteHershey, PA Active Research Program	Active Research Program	1	—	37.0
71	The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory Active Research Program	Active Research Program	1	—	37.0
72	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	1	—	37.0
73	UofL James Graham Brown Cancer CenterLouisville, KY Active Research Program	Active Research Program	1	—	37.0
74	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	37.0
75	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	1	—	37.0
76	Ellis Fischel Cancer Center, MU Health CareColumbia, MO Active Research Program	Active Research Program	1	—	37.0
77	Northwell Health Cancer InstituteNew York, NY Active Research Program	Active Research Program	1	—	37.0
78	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	1	—	37.0
79	Murtha Cancer Center at Walter Reed BethesdaBethesda, MD Active Research Program	Active Research Program	1	—	37.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →